Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Walavan Sivakumar

Neurological Surgery Torrance, CA Medical Doctor

NPI 1952627911 CMS profile 4221055

5215 Torrance Blvd Ste 300, Torrance, CA 90503

Open in the dashboard

General payments

$130,201

248 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Walavan Sivakumar of Torrance, CA is reported in the CMS Open Payments database as having received $130,201 across 248 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $60,997 72
2024 General $10,582 31
2023 General $14,937 36
2022 General $12,236 20
2021 General $8,127 38
2020 General $17,228 33
2019 General $6,094 18

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Walavan Sivakumar
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Walavan Sivakumar were reported at $60,997. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Walavan Sivakumar Neurological Surgery median Middle half National median
2019 $6,094 $582 $138–$3,006 $163
2020 $17,228 $294 $76–$2,174 $114
2021 $8,127 $387 $105–$2,432 $132
2022 $12,236 $542 $139–$2,989 $149
2023 $14,937 $534 $145–$2,697 $160
2024 $10,582 $574 $155–$3,046 $164
2025 $60,997 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $106,406 134 payments
  2. Carl Zeiss Meditec, Inc. $9,045 9 payments
  3. Carl Zeiss Meditec USA, Inc. $5,000 4 payments
  4. Globus Medical, Inc. $3,092 10 payments
  5. Integra LifeSciences Corporation $1,522 5 payments
  6. NICO Corporation $926 1 payment
  7. Biogen, Inc. $800 1 payment
  8. Bioventus LLC $725 1 payment
  9. AbbVie, Inc. $284 12 payments
  10. KARL STORZ Endoscopy-America $244 2 payments
  11. Other $2,157 69 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $97,600 58 payments
  2. Travel and Lodging $17,950 49 payments
  3. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $7,250 4 payments
  4. Food and Beverage $4,774 125 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,500 2 payments
  6. Education $126 10 payments
Products named General payments · program years 2019–2025
  1. NICO MYRIAD $32,303 18 payments
  2. NICO BRAINPATH $32,286 14 payments
  3. NICO FLUID SYSTEM $32,114 13 payments
  4. NICO AUTOMATED PRESERVATION SYSTEM $32,114 13 payments
  5. NICO BRAINPATH APPROACH $32,114 13 payments
  6. CORE $30,457 32 payments
  7. SPETZLER-MALIS $10,506 11 payments
  8. NEW PRODUCT DEVELOPMENT $6,663 12 payments
  9. SONOPET IQ $6,353 10 payments
  10. KINEVO 900 $3,000 2 payments
  11. Other $17,620 146 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 52 billing codes

Paid by Medicare

$204,633

Medicare's payments for the services billed

Medicare patients

433

Average age 76

Services billed

1,099

243 women, 190 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 61%
Diabetes 40%
Chronic kidney disease 34%
Ischemic heart disease 33%
Depression 30%
Heart failure 27%
Atrial fibrillation 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Xeomin
  • Merz Pharmaceuticals, LLC $27
$27 — —
UBRELVY
  • AbbVie, Inc. $14
$14 — —
BOTOX
  • AbbVie, Inc. $14
$14 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

248 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record